These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 769262)

  • 1. Immunologic models to study cardiac allograft rejection and prolongation.
    Guttmann RD
    Transplant Proc; 1976 Mar; 8(1):31-5. PubMed ID: 769262
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells.
    Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T
    Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of individual minor histocompatibility antigens in cardiac allograft rejection.
    Peugh WN; Wood KJ; Shreffler DC; Morris PJ; Morton-Bolman R
    Transplant Proc; 1989 Feb; 21(1 Pt 1):801-2. PubMed ID: 2650274
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of genetically defined nude mice in the study of the mixed leukocyte reaction.
    Croy BA; Osoba D
    J Immunol; 1974 Nov; 113(5):1626-34. PubMed ID: 4278870
    [No Abstract]   [Full Text] [Related]  

  • 5. Humoral immunity in allograft rejection. The role of cytotoxic alloantibody in hyperacute rejection and enhancement of rat cardiac allografts.
    Oluwole SF; Tezuka K; Wasfie T; Stegall MD; Reemtsma K; Hardy MA
    Transplantation; 1989 Nov; 48(5):751-5. PubMed ID: 2815247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo visualization of cardiac allograft rejection and trafficking passenger leukocytes using bioluminescence imaging.
    Tanaka M; Swijnenburg RJ; Gunawan F; Cao YA; Yang Y; Caffarelli AD; de Bruin JL; Contag CH; Robbins RC
    Circulation; 2005 Aug; 112(9 Suppl):I105-10. PubMed ID: 16159800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells.
    Carlquist JF; Shelby J; Hammond EH; Greenwood JH; Anderson JL
    Immunology; 1994 May; 82(1):149-53. PubMed ID: 7913913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of 51 Cr-labeled sensitized lymphocytes at the allograft region: a possible diagnostic test in organ transplantation.
    Goren G; Berke G; Urca I
    Surgery; 1972 Apr; 71(4):513-21. PubMed ID: 5021068
    [No Abstract]   [Full Text] [Related]  

  • 9. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
    Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
    Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pioglitazone prevents acute and chronic cardiac allograft rejection.
    Kosuge H; Haraguchi G; Koga N; Maejima Y; Suzuki J; Isobe M
    Circulation; 2006 Jun; 113(22):2613-22. PubMed ID: 16735678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between cellular manifestations of allograft response and graft rejection times.
    Viklický V; Polácková M
    Folia Biol (Praha); 1974; 20(2):125-32. PubMed ID: 4140110
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of the cellular immune response to HL-A antigens in human renal allograft recipients.
    Falk RE; Guttmann RD; Falk JA; Beaudoin JG; Deveber G; Morehouse DD; Wilson DR
    Clin Exp Immunol; 1973 May; 14(1):47-56. PubMed ID: 4577287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 14. Transplantation analysis of the H-2 system.
    Démant P; Graff RJ
    Transplant Proc; 1973 Mar; 5(1):267-70. PubMed ID: 4572100
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prolongation of allograft survival in mice by transplantation antigens incubated with normal serum. 1. Identification of the active serum fraction].
    Elie R; Liabeuf A; Lamoureux G
    Ann Immunol (Paris); 1973 Nov; 124(4):539-54. PubMed ID: 4134957
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of donor and recipient B7-1 (CD80) in allograft rejection.
    Zheng XX; Sayegh MH; Zheng XG; Li Y; Linsley PS; Peach R; Borriello F; Strom TB; Sharpe AH; Turka LA
    J Immunol; 1997 Aug; 159(3):1169-73. PubMed ID: 9233610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac transplantation in mice. IV. Relationship between antithymocyte-globulin (ATG) dose, allograft survival and anti-ATG immunity.
    Judd KP; Bryant CJ; Ruckman RJ; Trentin JJ
    Rev Eur Etud Clin Biol; 1971 Dec; 16(10):1002-6. PubMed ID: 4400851
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphocyte subsets in heart allograft rejection in a rat model: effect of in vitro generated suppressor cells.
    Lowry RP; Shadur CA; Duarte A; Strom TB; Carpenter CB
    Transplant Proc; 1981 Jun; 13(2):1428-31. PubMed ID: 6454287
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac transplantation in mice. V. Prolongation of allografts with cell-free extracts and antithymocyte globulin.
    Judd KP; Trentin JJ
    Transplantation; 1973 Oct; 16(4):351-8. PubMed ID: 4583149
    [No Abstract]   [Full Text] [Related]  

  • 20. [Extended survival of allographs in mice following the injection of transplantation antigens pre-treated with normal serum. II. Mode of action (author's transl)].
    Elie R; Lamoureux G
    Ann Immunol (Paris); 1974 Jun; 125 C(4):645-53. PubMed ID: 4615620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.